Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.

Son KB, Lopert R, Gleeson D, Lee TJ.

Open source

DOI
10.1186/s12992-018-0423-0
Published
2018-10-24
Container
Global Health
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12992-018-0423-0,
  title = {Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.},
  author = {Son KB and  Lopert R and  Gleeson D and  Lee TJ.},
  year = {2018},
  journal = {Global Health},
  doi = {10.1186/s12992-018-0423-0},
  url = {https://doi.org/10.1186/s12992-018-0423-0}
}

RIS

TY  - JOUR
TI  - Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.
AU  - Son KB
AU  -  Lopert R
AU  -  Gleeson D
AU  -  Lee TJ.
PY  - 2018
JO  - Global Health
DO  - 10.1186/s12992-018-0423-0
UR  - https://doi.org/10.1186/s12992-018-0423-0
ER  - 

APA

KB, S., R, L., D, G., & TJ., L. (2018). Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.. Global Health. https://doi.org/10.1186/s12992-018-0423-0

Source records